Ms Nadia Traficante
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
94 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762026
Research grants (ARC, NHMRC, MRFF)
Identifying the Key to Treatment Resistance in Ovarian Cancer
2025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994012025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994042025
Journal article
Co-Amplification Of CCNE1 And AKT2 As Prognostic Biomarker And Therapeutic Target In Tubo-Ovarian High-Grade Serous Carcinoma
DOI: 10.1016/j.ijgc.2025.1016842024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
RECENT SCHOLARLY WORKS
2024
Journal article
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
DOI: 10.1172/JCI1795012024
Journal article
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
DOI: 10.1038/s41698-024-00519-82024
Journal article
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
DOI: 10.1038/s41525-024-00395-y2024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y2024
Journal article
752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
DOI: 10.1016/j.annonc.2024.08.813